publication venue for
- Therapy innovations: tyrosine kinase inhibitors for the treatment of pancreatic neuroendocrine tumors.. 30 Suppl 1. 2011
- Eicosanoid signaling in carcinogenesis of colorectal cancer. 2018
- Targeting cellular and molecular drivers of head and neck squamous cell carcinoma: current options and emerging perspectives. 2016
- Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy. 2011
- Functional significance of vascular endothelial growth factor receptors on gastrointestinal cancer cells. 2007
- Bone marrow cells in the 'pre-metastatic niche': within bone and beyond. 2006
- Clinical patterns of metastasis. 2006
- Individualized therapy of disseminated cancer using malignant melanoma as a model. 2006
- Molecular targeting of the lymphovascular system for imaging and therapy. 2006
- Antibody-based therapeutics: focus on prostate cancer. 2005
- Prostate-specific membrane antigen (PSMA)-specific monoclonal antibodies in the treatment of prostate and other cancers. 1999
- Mechanistic concepts in androgen-dependence of prostate cancer. 1998
- Role of p27 in prostate carcinogenesis. 1998
- The clinical role of molecular genetics in soft tissue tumor pathology. 1997
- Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis. 1990